{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:21:31Z","timestamp":1790767291987,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T00:00:00Z","timestamp":1498089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T00:00:00Z","timestamp":1498089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00246-017-1652-3","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T03:26:10Z","timestamp":1498101970000},"page":"1247-1250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Development of Pulmonary Hypertension During Treatment with Diazoxide: A Case Series and Literature Review"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7997-999X","authenticated-orcid":false,"given":"Matthew R.","family":"Timlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander B.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e I.","family":"Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candace S.","family":"Percival","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,22]]},"reference":[{"issue":"2","key":"1652_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.6065\/apem.2014.19.2.57","volume":"19","author":"T Yorifuji","year":"2014","unstructured":"Yorifuji T (2014) Congenital hyperinsulinism: current status and future perspectives. Ann Pediatr Endocrinol Metab 19(2):57\u201368","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"1652_CR2","first-page":"2","volume":"69","author":"K Hussain","year":"2008","unstructured":"Hussain K (2008) Diagnosis and management of hyperinsulinaemic hypoglycaemia of infancy. Horm Res 69:2\u201313","journal-title":"Horm Res"},{"key":"1652_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4274\/Jcrpe.821","volume":"4","author":"Z Mohamed","year":"2012","unstructured":"Mohamed Z, Arya VB, Hussain K (2012) Hyperinsulinaemic hypoglycaemia:genetic mechanisms, diagnosis and management. J Clin Res Pediatr Endocrinol 4:169\u2013181","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"1652_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1750-1172-6-63","volume":"6","author":"JB Arnoux","year":"2011","unstructured":"Arnoux JB, Verkarre V, Saint-Martin C, Montravers F, Brassier A, Valayannopoulos V et al (2011) Congenital hyperinsulinism: current trends in diagnosis and therapy. Orphanet J Rare Dis 6:63","journal-title":"Orphanet J Rare Dis"},{"key":"1652_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1373\/clinchem.2007.098988","volume":"54","author":"AA Palladino","year":"2008","unstructured":"Palladino AA, Bennett MJ, Stanley CA (2008) Hyperinsulinism in infancy and childhood: when an insulin level is not always enough. Clin Chem 54:256\u2013263","journal-title":"Clin Chem"},{"key":"1652_CR6","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.beem.2013.06.005","volume":"27","author":"DD De Leon","year":"2013","unstructured":"De Leon DD, Stanley CA (2013) Determination of insulin for the diagnosis of hyperinsulinemic hypoglycemia. Best Pract Res Clin Endocrinol Metab 27:763\u2013769","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1652_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.earlhumdev.2010.05.003","volume":"86","author":"JB Arnoux","year":"2010","unstructured":"Arnoux JB, de Lonlay P, Ribeiro MJ, Hussain K, Blankenstein O, Mohnike K et al (2010) Congenital hyperinsulinism. Early Hum Dev 86:287\u2013294","journal-title":"Early Hum Dev"},{"key":"1652_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0021-9681(64)90037-2","volume":"17","author":"R Okun","year":"1964","unstructured":"Okun R, Wilson WR, Gelfand MD (1964) The hyperglycemic effect of hypotensive drugs. J Chronic Dis 17:31\u201339","journal-title":"J Chronic Dis"},{"key":"1652_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0140-6736(64)92414-6","volume":"1","author":"F Wolff","year":"1964","unstructured":"Wolff F (1964) Diazoxide hyperglycaemia and its continued relief by tolbutamide. Lancet 1:309\u2013310","journal-title":"Lancet"},{"issue":"2","key":"1652_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.pharmthera.2013.06.007","volume":"140","author":"WA Coetzee","year":"2013","unstructured":"Coetzee WA (2013) Multiplicity of effectors of the cardioprotective agent, diazoxide. Pharmacol Ther 140(2):167\u2013175","journal-title":"Pharmacol Ther"},{"key":"1652_CR11","unstructured":"FDA Drug Safety Communication: Pulmonary Hypertension in Infants and Newborns July 2015. Available at: http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm455125.htm"},{"issue":"7","key":"1652_CR12","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1460-9592.2004.01276.x","volume":"14","author":"P Silvani","year":"2004","unstructured":"Silvani P, Camporesi A, Mandelli A, Wolfler A, Salvo I (2004) A case of severe diazoxide toxicity. Paediatr Anaesth 14(7):607\u2013609","journal-title":"Paediatr Anaesth"},{"issue":"8","key":"1652_CR13","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1515\/JPEM.2007.20.8.939","volume":"20","author":"TD Nebesio","year":"2007","unstructured":"Nebesio TD, Hoover WC, Caldwell RL, Nitu ME, Eugster EA (2007) Development of pulmonary hypertension in an infant treated with diazoxide. J Pediatr Endocrinol Metab 20(8):939\u2013944","journal-title":"J Pediatr Endocrinol Metab"},{"key":"1652_CR14","unstructured":"Senguttuvan R, Saleh M, Wheeler M, Patel Ch, Chin C and Patel P. Diazoxide induced pulmonary hypertension in an infant. Endocrine Society\u2019s 96th Annual Meeting and Expo, Chicago, 21\u201324 June 2014"},{"issue":"1","key":"1652_CR15","first-page":"1","volume":"1","author":"A Albahri Zi Luke\u0161","year":"2015","unstructured":"Albahri Zi Luke\u0161 A, Myn\u00e1\u0159ov\u00e1 K, Krylov\u00e1 K, Al Mawiri A, Hussain K, Neumann D (2015) Development of pulmonary hypertension in an infant treated with diazoxide for hyperinsulinism, a case report and literature review. Am J Pediatr 1(1):1\u20133","journal-title":"Am J Pediatr"},{"issue":"7\u20138","key":"1652_CR16","first-page":"603","volume":"24","author":"F Demirel","year":"2011","unstructured":"Demirel F, Unal S, \u00c7etin II, Esen I, Arasli A (2011) Pulmonary hypertension and reopening of the ductus arteriosus in an infant treated with diazoxide. J Pediatr Endocrinol Metab 24(7\u20138):603\u2013605","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5","key":"1652_CR17","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s12325-008-0049-3","volume":"25","author":"D Yildizdas","year":"2008","unstructured":"Yildizdas D, Erdem S, K\u00fc\u00e7\u00fckosmanoglu O, Yilmaz M, Y\u00fcksel B (2008) Pulmonary hypertension, heart failure and neutropenia due to diazoxide therapy. Adv Ther. 25(5):515\u2013519","journal-title":"Adv Ther."},{"issue":"5 Pt 1","key":"1652_CR18","first-page":"L950","volume":"273","author":"BC Sheridan","year":"1997","unstructured":"Sheridan BC, McIntyre RC Jr, Meldrum DR, Fullerton DA (1997) KATP channels contribute to beta- and adenosine receptor-mediated pulmonary vasorelaxation. Am J Physiol 273(5 Pt 1):L950\u2013L956","journal-title":"Am J Physiol"},{"issue":"2","key":"1652_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.pharmthera.2013.06.007","volume":"140","author":"WA Coetzee","year":"2013","unstructured":"Coetzee WA (2013) Multiplicity of effectors of the cardioprotective agent, Diazoxide. Pharmacol Ther 140(2):167\u2013175","journal-title":"Pharmacol Ther"},{"key":"1652_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM198001103020204","volume":"302","author":"WP Klinke","year":"1980","unstructured":"Klinke WP, Gilbert JAL (1980) Diazoxide in primary pulmonary hypertension. N Engl J Med 302:91\u201392","journal-title":"N Engl J Med"},{"key":"1652_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1136\/hrt.46.4.401","volume":"46","author":"J Buch","year":"1981","unstructured":"Buch J, Wennevold A (1981) Hazards of diazoxide in pulmonary hypertension. Br Heart J. 46:401\u2013403","journal-title":"Br Heart J."}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-017-1652-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-017-1652-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-017-1652-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:07:44Z","timestamp":1744175264000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-017-1652-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,22]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["1652"],"URL":"https:\/\/doi.org\/10.1007\/s00246-017-1652-3","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,22]]},"assertion":[{"value":"24 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All of the authors of this paper are employees of the United States Department of Defense, either the United States Army or United States Air Force, and have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}